Cancer clinical trials in the region Auvergne-Rhône-Alpes

328 currently recruiting clinical trials
Region Auvergne-Rhône-Alpes

Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 2 3 or more
Systemic Treatment-Naive
Hoffmann-La Roche
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR 1 Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access Lymphoma
B cell lymphoma Large B cell lymphoma 1
Systemic Treatment-Naive
Hoffmann-La Roche
Phase 3 Anal cancer #NCT06207981 #2023-505972-32-00
Locally Advanced
Radiotherapy Radiotherapy
Hôpital Privé Drome Ardèche - Clinique Générale - Ramsay Santé (Valence), Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon), Centre Hospitalier Métropole Savoie (Chambéry)
Fédération Francophone de Cancérologie Digestive
Phase 3 Breast cancer #NCT05952557 #2023-504031-41-00
HER2 Negative HR Positive Localized None Surgery Chemotherapy Radiotherapy Hormone therapy
Systemic Treatment-Naive
CHU Saint-Étienne (Saint-Priest-en-Jarez), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand ), Centre Hospitalier Annecy Genevois (Epagny Metz-Tessy)
AstraZeneca
Phase 3 Stomach and esophageal cancer #NCT06346197 #2023-506291-28-00
Stomach Oesogastric junction Esophagus Adenocarcinoma Locally Advanced Metastatic MSI/dMMR PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
HER2 Immunotherapy Immunotherapy
Centre Léon Bérard (Lyon)
Centre Léon Bérard
Phase 3 Lymphoma CLL & Richter's syndrome #NCT06973187 #2025-522860-34-00
B cell lymphoma CLL (Chronic Lymphocytic Leukemia) Lymphocytic lymphoma 1 2 3 or more Targeted therapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand)
BeiGene
Phase 3 Bladder / Urinary Tract / Urethral cancer #NCT06510374
Non-invasive bladder cancer Urothelial carcinoma Localized None Surgery
Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand)
Ferring Pharmaceuticals